Journal Watch

  • PD vs. Home HD for Severe Infections

    In a Finnish study of 536 patients using home dialysis, the risk of a severe infection (C-reactive protein of 100mg/L or higher) in year 1 of CAPD was 35%, APD was 25% and home HD was 11%. Over a 5-year period, compared to home HD, the hazard ratio of severe infection for APD was 2.2 and for CAPD, 2.8. PD peritonitis accounted for the difference.

    Read the abstract » | (added 2023-07-17)

    Tags: Home Dialysis, Severe Infection, C reactive Protein, CAPD, APD, HD, Home HD, PD Peritonitis

  • Home Dialyzor Telehealth Preferences

    A small study (n=34) that included surveys and 21 interviews found that 70% of home dialysis patients preferred face-to-face home visits, while 68% had previously had telehealth visits. Knowledge of telehealth was the main perceived barrier, while convenience and flexibility were the main benefits. Non-English speaking patients were at a disadvantage for telehealth.

    Read the abstract » | (added 2023-07-17)

    Tags: Home Dialysis, Home Visits, Telehealth

  • Value of an Integrated Home Dialysis Model in the United Kingdom: A Cost-Effectiveness Analysis

    This study aimed to determine the lifetime cost-effectiveness of increasing home hemodialysis as a treatment option for patients experiencing peritoneal dialysis technique failure compared with the current standard of care.

    Read the abstract » | (added 2023-07-17)

    Tags: Cost effective, Home Hemodialysis, Treatment Option, Peritoneal Dialysis Technique Failure

  • UK Target: 20+% on Home Dialysis

    Despite the many benefits of home therapies, PD and home HD remain underused. The UK now recommends a minimum 20% prevalence rate for home dialysis.

    Read the abstract » | (added 2023-06-14)

    Tags: PD, Home HD, Peritonitis

  • Pathophysiology of Encapsulating Peritoneal Sclerosis (EPS)

    EPS is a rare but often fatal complication of PD. Biopsy findings from Japan suggest that EPS is not sclerosis, but formation of a neo-membrane in response to a peritoneal injury.

    Read the abstract » | (added 2023-06-14)

    Tags: EPS, Sclerosis, Neo membrane

  • Intraperitoneal Sodium Thiosulphate for Calciphylaxis in PD

    Calciphylaxis, or extraskeletal calciphylaxis is a rare, life-threatening condition. In a case series, researchers demonstrated that intraperitoneal delivery of sodium thiosulphate was a safe, convenient, long-term alternative to IV therapy.

    Read the abstract » | (added 2023-06-14)

    Tags: Calciphylaxis, Sodium Thiosulphate, Intraperitoneal

  • Daily HD and Cardiovascular Risk factors

    In a 4-year study of 26 people using daily hemodialysis and 51 matched controls doing standard hemodiaysis, the daily treatments significantly improved blood pressure, calcium-phosphorus product, and hemoglobin levels. There was also a non-significant trend toward lower left ventricular mass index.

    Read the abstract » | (added 2023-06-14)

    Tags: Daily HD, Cardiovascular Risk Factors, Blood Pressure, Calcium phosphorus Product, Hemoglobin Levels

  • Hope Matters in PD

    Among 134 patients receiving PD in Hong Kong, those who were working, had a higher income, and were using a cycler for PD had higher hope scores, and there were correlations with age and social support. Higher hope scores were linked with better mental well-being and less severe depression.

    Read the abstract » | (added 2023-06-14)

    Tags: PD, PD Cycler, Work, Hope Score, Social Support, Mental Well being, Depression

  • Portable, Wearable, and Implantable Artificial Kidneys

    The need to continuously regenerate dialysate is a challenge for all portable, wearable, and implantable kidney replacement therapy options. Sorbent technology is one approach. New membrane materials can remove more uremic toxins than current ones. Combining these membranes with living kidney cells has potential as well.

    Read the abstract » | (added 2023-06-14)

    Tags: Dialysate, Portable, Wearable, Implantable Kidney, Kidney Replacement Therapy

  • Does Incremental PD Preserve Residual Kidney Function?

    Analysis of data from 154 patients in the randomized, controlled balANZ trial did not find a difference in the slope of ultrafiltration volume decline between full dose and incremental PD.

    Read the abstract » | (added 2023-06-14)

    Tags: Incremental PD, Residual Kidney Function, Ultrafiltration Volume